Variable | No. of patients (%) |
---|---|
Age, years; median (range) | 53 (30–73) |
Cutaneous primary | 17 (94) |
Unknown primary | 1 (6) |
Gender | |
Female | 12 (67) |
Male | 6 (33) |
Performance status (ECOG)a | |
0 | 11 (61) |
1 | 7 (39) |
Recurrent disease after prior surgery | 15 (83) |
Prior adjuvant HDIb | 6 (33) |
Presence of in-transit metastases | 12 (67) |
Estimated risk stage | |
IIIB | 2 (11) |
IIIC | 16 (89) |
Tumor mutational status | |
BRAFV600 | 9 (50) |
NRASQ61 | 5 (28) |
Unknown | 1 (5) |